Akero Therapeutics

Akero Therapeutics

Biotechnology, 601 Gateway BLVD Ste 350, South San Francisco, California, 94080, United States, 11-50 Employees

akerotx.com

  • twitter
  • LinkedIn

phone no Phone Number: 65********

Who is AKERO THERAPEUTICS

Akero Therapeutics is a clinical-stage cardio-metabolic company developing transformational treatments for non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. ...

Read More

map
  • 601 Gateway BLVD Ste 350, South San Francisco, California, 94080, United States Headquarters: 601 Gateway BLVD Ste 350, South San Francisco, California, 94080, United States
  • 2017 Date Founded: 2017
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from AKERO THERAPEUTICS

Akero Therapeutics Org Chart and Mapping

Employees

Dominick Villani

Vice President of Quality Assurance

Reshma Shringarpure

Vice President, Clinical Research and Medical Affairs

Kitty Yale

EVP and Chief Development Officer

Christopher Ayscue-Tse

Associate Director, Regulatory Affairs

Libette Luce

Vice President, Head of Regulatory Affairs

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Akero Therapeutics

Answer: Akero Therapeutics's headquarters are located at 601 Gateway BLVD Ste 350, South San Francisco, California, 94080, United States

Answer: Akero Therapeutics's phone number is 65********

Answer: Akero Therapeutics's official website is https://akerotx.com

Answer: Akero Therapeutics's revenue is $1 Million to $5 Million

Answer: Akero Therapeutics's SIC: 2834

Answer: Akero Therapeutics's NAICS: 325412

Answer: Akero Therapeutics has 11-50 employees

Answer: Akero Therapeutics is in Biotechnology

Answer: Akero Therapeutics contact info: Phone number: 65******** Website: https://akerotx.com

Answer: Akero Therapeutics is a clinical-stage cardio-metabolic company developing transformational treatments for non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. Akero's lead product candidate, efruxifermin (EFX), an engineered Fc-FGF21 fusion protein, is currently being evaluated in a Phase 2b clinical trial as a potential treatment for NASH. Akero is headquartered in South San Francisco.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access